المؤلفون: Yu Kataoka, Ryo Nishikawa, Marenao Tanaka, Masato Furuhashi, Masayuki Koyama, Hirofumi Ohnishi, Shigeyuki Saitoh, Kazuaki Shimamoto, Akiko Sakai, Yukimura Higashiura

المصدر: Journal of Atherosclerosis and Thrombosis. 29:1275-1284

مصطلحات موضوعية: Male, medicine.medical_specialty, Iron, Population, Chronic liver disease, Cohort Studies, Non-alcoholic Fatty Liver Disease, Internal medicine, Internal Medicine, Humans, Medicine, Obesity, Subtilisins, education, Blood urea nitrogen, Triglycerides, education.field_of_study, business.industry, PCSK9, Biochemistry (medical), Fatty liver, gamma-Glutamyltransferase, medicine.disease, Endocrinology, Female, Proprotein Convertase 9, Cardiology and Cardiovascular Medicine, business, Body mass index, Dyslipidemia

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01f4084eb90756da02e8df27629cc0e3Test
https://doi.org/10.5551/jat.63159Test

المؤلفون: Xuan Li, Zhengzhong Wang, Qingjiao Sun, Qiang Geng

المصدر: Cardiology Journal. 29:574-581

مصطلحات موضوعية: medicine.medical_specialty, medicine.diagnostic_test, business.industry, PCSK9, PCSK9 Inhibitors, General Medicine, Odds ratio, Bococizumab, law.invention, Evolocumab, Tolerability, Randomized controlled trial, Cardiovascular Diseases, law, Internal medicine, Cardiology, medicine, Humans, Proprotein Convertase 9, Cardiology and Cardiovascular Medicine, Lipid profile, business, Randomized Controlled Trials as Topic, Alirocumab

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a824d02ecc44635fe4a2343b6453716cTest
https://doi.org/10.5603/cj.a2021.0110Test

المؤلفون: Masa-aki Kawashiri, Tomohiro Hirao, Jun Kunikata, Tsuyoshi Sasaki, Keiji Matsunaga, Takuji Fujisawa, Kazushige Dobashi, Yoichi Hoshikawa, Katsunori Yokoyama, Shigeru Ito, Takashi Kusaka, Ichiro Yokota, Asako Mizobuchi, Shohei Ishikawa, Hayato Tada, Takashi Iwase, Tetsuo Minamino, Hai Ying Fu

المصدر: Journal of Atherosclerosis and Thrombosis. 29:839-849

مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, Apolipoprotein B, Familial hypercholesterolemia, medicine.disease_cause, Hyperlipoproteinemia Type II, Japan, Internal Medicine, medicine, Humans, Child, Apolipoproteins B, Genetic testing, Lipoprotein cholesterol, Mutation, medicine.diagnostic_test, biology, business.industry, Biochemistry (medical), Genetic disorder, Area under the curve, Cholesterol, LDL, Lipid screening, medicine.disease, biology.protein, lipids (amino acids, peptides, and proteins), Proprotein Convertase 9, Cardiology and Cardiovascular Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b6bcd056113f9b91bb461e2875625afTest
https://doi.org/10.5551/jat.62780Test

المؤلفون: Anca Pantea Stoian, Alexandros Sachinidis, Federica Fogacci, Ali A. Rizvi, Manfredi Rizzo, Andrej Janez, Dragana Nikolic, Arrigo F G Cicero, Yajnavalka Banerjee

المساهمون: Banerjee Y., Pantea Stoian A., Cicero A.F.G., Fogacci F., Nikolic D., Sachinidis A., Rizvi A.A., Janez A., Rizzo M., Banerjee Y, Pantea Stoian A, Cicero AFG, Fogacci F, Nikolic D, Sachinidis A, Rizvi AA, Janez A, Rizzo M

المصدر: Expert Opinion on Drug Safety. 21:9-20

مصطلحات موضوعية: Drug, Small interfering RNA, media_common.quotation_subject, Hypercholesterolemia, Placebo, Bioinformatics, LDL, PCSK9, RNA interference, medicine, Animals, Humans, Pharmacology (medical), Gene Silencing, RNA, Small Interfering, Adverse effect, Dyslipidemias, media_common, therapy, business.industry, General Medicine, medicine.disease, Clinical trial, Cardiovascular Diseases, Atherosclerosis, inclisiran, LDL, PCSK9, RNA, therapy, Animals, Cardiovascular Diseases, Dyslipidemias, Gene Silencing, Humans, Hypercholesterolemia, Proprotein Convertase 9, RNA, Small Interfering, Atherosclerosi, RNA, Proprotein Convertase 9, business, inclisiran, Dyslipidemia

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a008fe9ea51505dc2fead510398c85feTest
https://doi.org/10.1080/14740338.2022.1988568Test

المؤلفون: Alessio Buonaiuto, Maria Donata Di Taranto, Ilenia Calcaterra, Marco Gentile, Paolo Rubba, Giuliana Fortunato, Carola Giacobbe, M. Tripaldella, Matteo Nicola Dario Di Minno, Gabriella Iannuzzo, Francesco Forte

المساهمون: Iannuzzo, G., Buonaiuto, A., Calcaterra, I., Gentile, M., Forte, F., Tripaldella, M., Di Taranto, M. D., Giacobbe, C., Fortunato, G., Rubba, P. O., Di Minno, M. N. D.

المصدر: Nutrition, Metabolism and Cardiovascular Diseases. 32:684-691

مصطلحات موضوعية: Adult, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Familial hypercholesterolemia, Medicine (miscellaneous), medicine.disease_cause, Single Center, Gastroenterology, Hyperlipoproteinemia Type II, Proprotein convertase subtilisin/kexin type 9 inhibitors, Internal medicine, Humans, Medicine, Low-density lipoprotein cholesterol, Aged, Mutation, Nutrition and Dietetics, business.industry, PCSK9, PCSK9 Inhibitors, Autosomal dominant trait, Middle Aged, Proprotein convertase, medicine.disease, Receptors, LDL, Low-density lipoprotein receptor gene, LDL receptor, Kexin, lipids (amino acids, peptides, and proteins), Proprotein Convertase 9, Cardiology and Cardiovascular Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14be8705d8c715eb5ab055c4465f342cTest
https://doi.org/10.1016/j.numecd.2021.10.025Test

المؤلفون: Przemysław Podhajski, Aldona Kubica, Eliano Pio Navarese, Roman Junik, Piotr Adamski, Przemysław Magielski, Jarosław Pinkas, Jacek Kubica

المصدر: Cardiology Journal. 29:140-147

مصطلحات موضوعية: Oncology, 2019-20 coronavirus outbreak, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), SARS-CoV-2, business.industry, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), PCSK9, COVID-19, Carbidopa, General Medicine, Levodopa, Drug Combinations, Internal medicine, Cardiology, Humans, Medicine, In patient, Proprotein Convertase 9, Stage (cooking), Cardiology and Cardiovascular Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca9d654f52f175e8e60005a43c9f7fbaTest
https://doi.org/10.5603/cj.a2021.0148Test

المؤلفون: Suowen Xu, Amir Abbas Momtazi-Borojeni, Amirhossein Sahebkar, Matteo Pirro

المصدر: Current Medicinal Chemistry. 29:980-999

مصطلحات موضوعية: Statin, medicine.drug_class, medicine.medical_treatment, Inclisiran, Pharmacology, Monoclonal antibody, Biochemistry, LDL, PCSK9, Drug Discovery, medicine, Humans, Alirocumab, business.industry, PCSK9 Inhibitors, Organic Chemistry, Cholesterol, LDL, Immunotherapy, Proprotein convertase, Evolocumab, Cholesterol, LDL receptor, Molecular Medicine, Proprotein Convertase 9, business, Vaccine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea6f53bc954dda6f5d3b85c0b5ad98b2Test
https://doi.org/10.2174/0929867328666211027125245Test

المؤلفون: Roberta Maria Antonello, Matteo Bassetti, Chiara Sepulcri, Laura Labate, Stefano Di Bella, Laura Magnasco, Daniele Roberto Giacobbe, Roberto Luzzati

المساهمون: Magnasco, Laura, Sepulcri, Chiara, Antonello, Roberta Maria, Di Bella, Stefano, Labate, Laura, Luzzati, Roberto, Giacobbe, Daniele Roberto, Bassetti, Matteo

المصدر: Current Medicinal Chemistry. 29:1000-1015

مصطلحات موضوعية: protozoal infection, Communicable Diseases, Biochemistry, Dengue fever, sepsis, Pathogenesis, Sepsis, Immunity, Drug Discovery, medicine, Animals, Humans, Loss function, Pharmacology, Innate immune system, SARS-CoV-2, business.industry, Septic shock, Organic Chemistry, bacterial infection, COVID-19, HIV, medicine.disease, immunity, Immunity, Innate, HCV, viral infection, Immunology, Molecular Medicine, sepsi, Proprotein Convertase 9, business, Malaria

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ece390081e2766f6f25026623761903aTest
https://doi.org/10.2174/0929867328666210714160343Test

المؤلفون: Luca Liberale, Giovanni G. Camici, Seyed Soheil Saeedi Saravi, Dimitri Patriki, Jürg H. Beer

المصدر: Current Medicinal Chemistry. 29:251-267

مصطلحات موضوعية: medicine.medical_specialty, Inflammation, Context (language use), Biochemistry, LDL, PCSK9, Internal medicine, Drug Discovery, medicine, Humans, Receptor, Pharmacology, business.industry, PCSK9 Inhibitors, Organic Chemistry, Lipid metabolism, Lipid, Atherosclerosis, Cardiovascular disease, Proprotein convertase, Endocrinology, Molecular Medicine, Kexin, lipids (amino acids, peptides, and proteins), Proprotein Convertase 9, medicine.symptom, business, Lipoprotein

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17de8e2fa9344fb16412ffceaec1a6ffTest
https://doi.org/10.2174/0929867328666210707192625Test

المؤلفون: Anton Dodek, Mark D. Benson, Christopher P. Cannon, Benjamin M. Scirica, Calum A. MacRae, Tiffany V. Bui, Lina Matta, Kira Chaney, David Zelle, Jorge Plutzky, Michael Kraft, Akshay S. Desai, Marian McPartlin, Thomas A. Gaziano

المصدر: American Heart Journal. 243:15-27

مصطلحات موضوعية: medicine.medical_specialty, Statin, medicine.drug_class, Population, Type 2 diabetes, Ezetimibe, Internal medicine, Health care, medicine, Humans, education, education.field_of_study, business.industry, Medical record, Cholesterol, LDL, Guideline, medicine.disease, Cholesterol, Diabetes Mellitus, Type 2, Cohort, Population Health Management, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Proprotein Convertase 9, Cardiology and Cardiovascular Medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d54c8f03e993b9dd9c90e7b3e76815a5Test
https://doi.org/10.1016/j.ahj.2021.08.017Test